EcoDrugPlus

Ensembl ID : ENSRFEG00010003187
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSRFEG00010002935
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSRFEG00010012130
Gene Symbol: -
Cross references: -
116 Possible Orthologues:

Ensembl ID : ENSRFEG00010008166
Gene Symbol: -
Cross references: -
60 Possible Orthologues:

Ensembl ID : ENSRFEG00010002898
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSRFEG00010002452
Gene Symbol: -
Cross references: -
295 Possible Orthologues:

Ensembl ID : ENSRFEG00010001898
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSRFEG00010022093
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSRFEG00010021943
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSRFEG00010021265
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSRFEG00010021341
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSRFEG00010020880
Gene Symbol: -
Cross references: -
116 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).